Takao Saruta

Title: Takao Saruta: Innovator in Medical Examination Methods

Introduction

Takao Saruta is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical examination methods, particularly in understanding the role of opioid peptides in pruritic diseases. With a total of 2 patents, his work has the potential to impact therapeutic approaches in dermatology.

Latest Patents

One of Saruta's latest patents is a method for examining the involvement of opioid peptides in pruritis. This innovative method involves measuring multiple opioid peptides or opioid receptors in blood cells, body fluids, or tissues, and calculating their ratios. It can specifically be applied to pruritic diseases, helping to determine whether opioids are involved and whether therapy with an opioid agonistic and/or antagonistic antipruritus agent is appropriate. Another notable patent is related to 25-hydroxyvitamin D3-1α-hydroxylase and the DNA encoding the hydroxylase, which further showcases his expertise in medical research.

Career Highlights

Throughout his career, Takao Saruta has worked with esteemed companies such as Toray Industries, Inc. and Kyowa Hakko Kogyo Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Saruta has collaborated with notable colleagues, including Hiroo Kumagai and Hideharu Anazawa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical research.

Conclusion

Takao Saruta's contributions to the field of medical examination methods highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing our understanding of complex medical conditions.